Table 2 Tumor distribution and categorization

   All except NSCLC with molecularly targeted therapy^a

187

18

R

   NSCLC with molecularly targeted therapy

26

2.6

M

Multiple myeloma

138

14

S

   Hormone dependent

137

14

S

   Hormone independent

40

4

M

 Renal cell carcinoma

95

9.4

M

 Malignant lymphoma

43

4.3

S

 Malignant melanoma

42

4.2

R

   Hormone dependent

36

3.6

M

   Hormone independent

36

3.6

S

 Head and neck cancer

28

2.8

R

 Colon and rectal cancer

27

2.7

R

 NSCLC with molecularly targeted therapy

26

2.6

M

 Esophageal cancer

25

2.5

R

 Sarcoma

25

2.5

M

 Thyroid cancer

20

2

S

 Hepatocellular carcinoma

16

1.6

R

 Other gynecological cancer

14

1.4

M

 Other urological cancer

11

1.1

R

 Pancreatic cancer

6

0.6

R

 Gallbladder cancer

2

0.2

R

 Gastric cancer

1

0.1

R

 Cervical cancer

1

0.1

R

 Unknown primary

18

1.8

R

 Other^b

38

3.8

M